Total
0
Shares
Advanced Human Imaging (ASX:AHI) - CEO, Vlado Bosanac - The Market Herald
CEO, Vlado Bosanac
Source: Advanced Human Imaging
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Advanced Human Imaging (AHI) signs a binding term sheet with Toronto-based digital health provider Cubert Inc
  • Under the term sheet, AHI will integrate its technology into Cubert's FitTrack platform to release a new offering called FitScan
  • FitScan will enable users to privately check, track and assess their wellness as well as predict potential health risks from their phone
  • Launch is expected in Q1 2022 and the platform will be available across both iOS and Android devices
  • AHI is steady on the market and shares are trading at $1.26 at 3:44 pm AEST

Advanced Human Imaging (AHI) has signed a binding term sheet with Toronto-based digital health provider Cubert Inc.

Cubert's preventative health screening app FitTrack has a global audience of over one million active users.

FitTrack is supported and used by celebrity ambassadors and collaborators such as reality TV star Khloe Kardashian.

Under the term sheet, AHI will integrate its technology into the FitTrack platform to release a new offering called FitScan.

FitScan will be available in Q1 2022 across both iOS and Android devices and will allow users to privately check, track and assess wellness as well as predict potential health risks all from their phone.

FitScan will include FaceScan which measures key health metrics such as heart rate, blood pressure, respiratory rate and risks associated with cardiovascular disease, heart attacks and strokes.

BodyScan will include innovative technology and image processing to determine body circumference, body composition and obesity and diabetes risks.

"Adding physical dimensions along with body composition to the FitTrack application will drive deeper engagement with existing users, whilst opening up the use case to a broader audience that have not yet purchased a FitTrack device," AHI Co-Founder and CEO Vlado Bosanac said.

AHI has the right to terminate the agreement if FitTrack fails to reach a minimum user number of 200,000 in the first year of commercial launch.

"We want to give our users the tools to take control of their personal health journeys, with AHI as our software partner, we are enabling FitTrack users to use their personal devices to perform simple but cutting-edge health assessments in the safety and comfort of their home," FitTrack Founder and CEO Jeff Lee said.

"The innovative software will launch in early 2022, cementing FitTrack's position at the leading-edge of the consumer health-tech industry and one step closer to providing a complete holistic health solution for consumers."

AHI was steady on the market with shares trading at $1.26 at 3:44 pm AEST.

AHI by the numbers
More From The Market Herald
BARD1 Life Sciences (ASX:BD1) - CEO, Leearne Hinch - The Market Herald

" BARD1 Life Sciences (ASX:BD1) updates the market on Q4

BARD1 Life Sciences (BD1) has reported advances across its sales, business development and commercialisation activities over the June quarter.
Incannex Healthcare (ASX:IHL) - Chief Medical Officer, Dr Sud Agarwal (centre) - The Market Herald

" Incannex Healthcare (ASX:IHL) has a progressive fourth quarter

Incannex Healthcare (IHL) has spent the fourth quarter progressing its cannabinoid pharmaceutical products and psychedelic medicine therapies.
Prescient Therapeutics (PTX) - CEO & Managing Director, Steven Yatomi Clarke - The Market Herald

" Prescient Therapeutics (ASX:PTX) advances clinical studies in June quarter

Prescient Therapeutics (PTX) has summarised its operations and cashflow for the June quarter.
Mesoblast (ASX:MSB) - Managing Director & CEO, Silviu Itescu - The Market Herald

" Mesoblast (ASX:MSB) trades lower following June quarterly report

Drug developer Mesoblast (MSB) is trading red following the release of its latest quarterly financial report.